Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viracta Therapeutics, Inc. (VIRX) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viracta Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1061027.
Total stock buying since 2005: $74,718,278.
Total stock sales since 2005: $88,033,307.
Total stock option exercises since 2005: $303,905.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 0 | $0 | 3,405 | $2,492 | 143,902 | $0 |
2023 | 0 | $0 | 13,023 | $15,737 | 161,806 | $0 |
2022 | 0 | $0 | 48,023 | $142,114 | 142,696 | $0 |
2021 | 8,000 | $44,480 | 39,867 | $191,809 | 142,286 | $99,395 |
2020 | 6,000 | $1,992 | 0 | $0 | 0 | $0 |
2019 | 2,512,000 | $1,506,072 | 0 | $0 | 0 | $0 |
2018 | 40,000 | $18,800 | 0 | $0 | 0 | $0 |
2017 | 481,500 | $1,026,001 | 0 | $0 | 0 | $0 |
2016 | 65,745 | $43,758 | 0 | $0 | 0 | $0 |
2015 | 1,800,000 | $1,520,699 | 1,296,835 | $4,515,628 | 0 | $0 |
2014 | 0 | $0 | 9,924,274 | $69,497,620 | 39,389 | $78,823 |
2013 | 0 | $0 | 30,054 | $151,667 | 55,054 | $125,687 |
2011 | 9,600 | $15,262 | 0 | $0 | 0 | $0 |
2010 | 179,736,352 | $49,430,892 | 1,176,345 | $1,121,505 | 0 | $0 |
2009 | 0 | $0 | 7,072,979 | $12,364,735 | 0 | $0 |
2007 | 1,362,400 | $6,034,192 | 0 | $0 | 0 | $0 |
2006 | 1,628,206 | $10,076,128 | 5,000 | $30,000 | 0 | $0 |
2005 | 714,286 | $5,000,002 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-11 | 0 | $0 | 0 | $0 | 34,253 | $0 |
2024-08 | 0 | $0 | 0 | $0 | 34,253 | $0 |
2024-05 | 0 | $0 | 0 | $0 | 34,254 | $0 |
2024-02 | 0 | $0 | 3,405 | $2,492 | 41,142 | $0 |
2023-11 | 0 | $0 | 3,720 | $1,860 | 41,142 | $0 |
2023-08 | 0 | $0 | 3,512 | $5,092 | 41,141 | $0 |
2023-05 | 0 | $0 | 3,635 | $5,161 | 41,143 | $0 |
2023-02 | 0 | $0 | 2,156 | $3,624 | 38,380 | $0 |
2022-11 | 0 | $0 | 5,648 | $15,360 | 45,269 | $0 |
2022-08 | 0 | $0 | 19,224 | $77,127 | 45,269 | $0 |
2022-05 | 0 | $0 | 16,758 | $31,855 | 32,108 | $0 |
2022-02 | 0 | $0 | 6,393 | $17,772 | 20,050 | $0 |
2021-12 | 0 | $0 | 0 | $0 | 7,000 | $6,300 |
2021-11 | 8,000 | $44,480 | 39,867 | $191,809 | 90,536 | $0 |
2021-09 | 0 | $0 | 0 | $0 | 10,000 | $9,000 |
2021-05 | 0 | $0 | 0 | $0 | 34,750 | $84,095 |
2020-05 | 6,000 | $1,992 | 0 | $0 | 0 | $0 |
2019-11 | 6,000 | $2,196 | 0 | $0 | 0 | $0 |
2019-07 | 2,500,000 | $1,500,000 | 0 | $0 | 0 | $0 |
2019-05 | 6,000 | $3,876 | 0 | $0 | 0 | $0 |
2018-12 | 40,000 | $18,800 | 0 | $0 | 0 | $0 |
2017-11 | 81,500 | $226,001 | 0 | $0 | 0 | $0 |
2017-10 | 400,000 | $800,000 | 0 | $0 | 0 | $0 |
2016-12 | 3,740 | $14,476 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-11-25 | Pomerantz Roger | Option Ex | 9,034 | .00 | 0 |
2024-11-25 | Royston Ivor | Option Ex | 25,219 | .00 | 0 |
2024-08-25 | Pomerantz Roger | Option Ex | 9,034 | .00 | 0 |
2024-08-25 | Royston Ivor | Option Ex | 25,219 | .00 | 0 |
2024-05-25 | Pomerantz Roger | Option Ex | 9,035 | .00 | 0 |
2024-05-25 | Royston Ivor | Option Ex | 25,219 | .00 | 0 |
2024-02-27 | Chevallard Daniel R. (CFO and COO) | Sale | 3,405 | .73 | 2,492 |
2024-02-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2024-02-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2024-02-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2023-11-28 | Chevallard Daniel R. (CFO and COO) | Sale | 3,720 | .50 | 1,860 |
2023-11-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2023-11-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2023-11-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2023-08-28 | Chevallard Daniel R. (CFO and COO) | Sale | 3,512 | 1.45 | 5,092 |
2023-08-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,888 | .00 | 0 |
2023-08-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2023-08-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2023-05-25 | Chevallard Daniel R. (CFO and COO) | Sale | 3,635 | 1.42 | 5,161 |
2023-05-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2023-05-25 | Pomerantz Roger (Director) | Option Ex | 9,035 | .00 | 0 |
2023-05-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2023-02-27 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 2,156 | 1.68 | 3,624 |
2023-02-25 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 4,127 | .00 | 0 |
2023-02-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2023-02-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2022-11-28 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 2,116 | 2.72 | 5,753 |
2022-11-28 | Chevallard Daniel R. (CFO and COO) | Sale | 3,532 | 2.72 | 9,607 |
2022-11-25 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 4,127 | .00 | 0 |
2022-11-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2022-11-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2022-11-25 | Royston Ivor (Director) | Option Ex | 25,219 | .00 | 0 |
2022-08-26 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 2,190 | 4.01 | 8,786 |
2022-08-26 | Chevallard Daniel R. (CFO and COO) | Sale | 3,655 | 4.02 | 14,678 |
2022-08-26 | Royston Ivor (CEO & President) | Sale | 13,379 | 4.01 | 53,663 |
2022-08-25 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 4,127 | .00 | 0 |
2022-08-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2022-08-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2022-08-25 | Royston Ivor (CEO & President) | Option Ex | 25,219 | .00 | 0 |
2022-05-26 | Chevallard Daniel R. (CFO and COO) | Sale | 3,596 | 1.90 | 6,835 |
2022-05-26 | Royston Ivor (CEO & President) | Sale | 13,162 | 1.90 | 25,020 |
2022-05-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2022-05-25 | Royston Ivor (CEO & President) | Option Ex | 25,219 | .00 | 0 |
2022-02-28 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 2,395 | 2.78 | 6,658 |
2022-02-28 | Chevallard Daniel R. (CFO and COO) | Sale | 3,998 | 2.78 | 11,114 |
2022-02-25 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 4,127 | .00 | 0 |
2022-02-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 6,889 | .00 | 0 |
2022-02-25 | Pomerantz Roger (Director) | Option Ex | 9,034 | .00 | 0 |
2021-12-29 | Royston Ivor (CEO & President) | Option Ex | 7,000 | .90 | 6,300 |
2021-11-29 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 2,591 | 4.82 | 12,486 |
2021-11-29 | Chevallard Daniel R. (CFO and COO) | Sale | 4,325 | 4.82 | 20,842 |
2021-11-29 | Royston Ivor (CEO & President) | Sale | 15,833 | 4.82 | 76,299 |
2021-11-26 | Rojkjaer Lisa (Chief Medical Officer) | Sale | 1,950 | 4.80 | 9,361 |
2021-11-26 | Chevallard Daniel R. (CFO and COO) | Sale | 3,254 | 4.80 | 15,622 |
2021-11-26 | Royston Ivor (CEO & President) | Sale | 11,914 | 4.80 | 57,199 |
2021-11-25 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 8,254 | .00 | 0 |
2021-11-25 | Chevallard Daniel R. (CFO and COO) | Option Ex | 13,777 | .00 | 0 |
2021-11-25 | Pomerantz Roger (Director) | Option Ex | 18,068 | .00 | 0 |
2021-11-25 | Royston Ivor (CEO & President) | Option Ex | 50,437 | .00 | 0 |
2021-11-15 | Royston Ivor (CEO & President) | Buy | 8,000 | 5.56 | 44,480 |
2021-09-28 | Chevallard Daniel R. (CFO and COO) | Option Ex | 10,000 | .90 | 9,000 |
2021-05-11 | Rojkjaer Lisa (Chief Medical Officer) | Option Ex | 34,750 | 2.42 | 84,095 |
2020-05-29 | Gullotta Tina (VP, Finance) | Buy | 6,000 | .33 | 1,992 |
2019-11-29 | Quinn William P. (See Remarks) | Buy | 6,000 | .37 | 2,196 |
2019-07-15 | Elms Steve (10% Owner) | Buy | 2,500,000 | .60 | 1,500,000 |
2019-05-31 | Quinn William P. (See Remarks) | Buy | 6,000 | .65 | 3,876 |
2018-12-10 | Quinn William P. (CFO,Sr.V.P. Finance, Corp.Dev.) | Buy | 40,000 | .47 | 18,800 |
2017-11-06 | Ubs Oncology Impact Fund L.p. | Buy | 16,200 | 2.77 | 44,874 |
2017-11-03 | Ubs Oncology Impact Fund L.p. | Buy | 40,000 | 2.89 | 115,600 |
2017-11-02 | Ubs Oncology Impact Fund L.p. | Buy | 25,300 | 2.59 | 65,527 |
2017-10-27 | Misfeldt Dayton | Buy | 400,000 | 2.00 | 800,000 |
2016-12-09 | Parker Geoffrey M. | Buy | 594 | 3.90 | 2,317 |
2016-12-08 | Parker Geoffrey M. | Buy | 3,146 | 3.87 | 12,159 |
2016-05-26 | Parker Geoffrey M. | Buy | 9,500 | .47 | 4,455 |
2016-05-25 | Parker Geoffrey M. | Buy | 22,505 | .49 | 10,937 |
2016-05-24 | Parker Geoffrey M. | Buy | 30,000 | .46 | 13,890 |
2015-12-21 | Misfeldt Dayton | Buy | 1,750,000 | .84 | 1,470,000 |
2015-08-25 | Swisher Daniel N Jr (President and CEO) | Buy | 12,216 | 1.01 | 12,338 |
2015-08-24 | Swisher Daniel N Jr (President and CEO) | Buy | 12,784 | 1.01 | 12,911 |
2015-07-24 | Misfeldt Dayton | Sale | 635,702 | 3.50 | 2,228,135 |
2015-07-24 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 635,702 | 3.46 | 2,199,528 |
2015-07-24 | Swisher Daniel N Jr (President and CEO) | Buy | 25,000 | 1.02 | 25,450 |
2015-07-24 | Swisher Daniel N Jr (President and CEO) | Sale | 12,715 | 3.46 | 43,981 |
2015-07-24 | Ketchum Steven B (Director) | Sale | 6,358 | 3.46 | 21,992 |
2015-07-24 | Bjerkholt Eric (EVP, CFO & Corp. Secretary) | Sale | 6,358 | 3.46 | 21,992 |
2014-08-29 | Nea 12 Gp, Llc (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Drant Ryan D (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Baskett Forest (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Kolluri Krishna Kittu (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Sandell Scott D (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Kerins Patrick J (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Barrett M James (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-29 | Barris Peter J (10% Owner) | Sale | 11,600 | 7.51 | 87,069 |
2014-08-28 | Misfeldt Dayton | Sale | 200,000 | 7.88 | 1,577,000 |
2014-08-28 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 200,000 | 7.88 | 1,577,000 |
2014-08-28 | Nea 12 Gp, Llc (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Drant Ryan D (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Baskett Forest (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Kolluri Krishna Kittu (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Sandell Scott D (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Kerins Patrick J (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Barrett M James (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-28 | Barris Peter J (10% Owner) | Sale | 146,800 | 7.87 | 1,154,875 |
2014-08-27 | Misfeldt Dayton | Sale | 100,700 | 8.16 | 822,014 |
2014-08-27 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 100,700 | 8.16 | 822,014 |
2014-08-27 | Nea 12 Gp, Llc (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Craig Adam R (EVP, Development & CMO) | Sale | 2,554 | 8.00 | 20,432 |
2014-08-27 | Swisher Daniel N Jr (President and CEO) | Sale | 5,000 | 8.00 | 40,000 |
2014-08-27 | Swisher Daniel N Jr (President and CEO) | Option Ex | 5,000 | 2.09 | 10,450 |
2014-08-27 | Drant Ryan D (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Baskett Forest (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Kolluri Krishna Kittu (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Sandell Scott D (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Kerins Patrick J (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Barrett M James (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-27 | Bjerkholt Eric (EVP, CFO & Corp. Secretary) | Sale | 10,000 | 8.00 | 80,000 |
2014-08-27 | Bjerkholt Eric (EVP, CFO & Corp. Secretary) | Option Ex | 10,000 | 1.74 | 17,400 |
2014-08-27 | Barris Peter J (10% Owner) | Sale | 108,300 | 8.17 | 884,811 |
2014-08-12 | Misfeldt Dayton | Sale | 37,100 | 6.77 | 251,241 |
2014-08-12 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 37,100 | 6.77 | 251,241 |
2014-08-12 | Nea 12 Gp, Llc (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Drant Ryan D (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Baskett Forest (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Kolluri Krishna Kittu (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Sandell Scott D (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Kerins Patrick J (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Barrett M James (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-12 | Barris Peter J (10% Owner) | Sale | 35,540 | 6.76 | 240,179 |
2014-08-11 | Misfeldt Dayton | Sale | 31,600 | 6.90 | 218,103 |
2014-08-11 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 31,600 | 6.90 | 218,103 |
2014-08-08 | Misfeldt Dayton | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Bay City Capital Fund V Co-investment Fund, L.p. (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Nea 12 Gp, Llc (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Drant Ryan D (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Baskett Forest (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Kolluri Krishna Kittu (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Sandell Scott D (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Kerins Patrick J (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Barrett M James (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-08-08 | Barris Peter J (10% Owner) | Sale | 675,000 | 6.62 | 4,468,500 |
2014-05-16 | Swisher Daniel N Jr (President and CEO) | Option Ex | 24,389 | 2.09 | 50,973 |
2013-11-08 | Ketchum Steven B | Sale | 10,503 | 5.08 | 53,365 |
2013-11-08 | Ketchum Steven B | Option Ex | 10,503 | 2.09 | 21,951 |
2013-11-07 | Ketchum Steven B | Sale | 19,551 | 5.03 | 98,302 |
2013-11-07 | Ketchum Steven B | Option Ex | 19,551 | 2.09 | 40,861 |
2013-06-18 | Swisher Daniel N Jr (President and CEO) | Option Ex | 25,000 | 2.52 | 62,875 |
2011-11-28 | Swisher Daniel N Jr (President and CEO) | Buy | 2,500 | 1.14 | 2,849 |
2011-11-21 | Swisher Daniel N Jr (President and CEO) | Buy | 2,100 | 1.18 | 2,478 |
2011-07-15 | Swisher Daniel N Jr (President and CEO) | Buy | 5,000 | 1.99 | 9,935 |
2010-10-08 | Bjerkholt Eric (Sr. VP, CFO & Corp. Secretary) | Buy | 100,000 | .31 | 30,900 |
2010-06-30 | Misfeldt Dayton | Buy | 23,824,450 | .28 | 6,551,723 |
2010-06-30 | Bay City Capital Fund V Co-investment Fund Lp (10% Owner) | Buy | 23,824,450 | .28 | 6,551,723 |
2010-06-30 | Swisher Daniel N Jr (President and CEO) | Buy | 476,487 | .28 | 131,033 |
2010-06-30 | Drant Ryan D (10% Owner) | Buy | 23,824,451 | .28 | 6,551,724 |
2010-06-30 | Ketchum Steven B (Sr. Vice President, R & D) | Buy | 238,243 | .28 | 65,516 |
2010-06-30 | Baskett Forest (10% Owner) | Buy | 23,824,451 | .28 | 6,551,724 |
2010-06-30 | Kolluri Krishna Kittu (10% Owner) | Buy | 23,824,451 | .28 | 6,551,724 |
2010-06-30 | Sandell Scott D (10% Owner) | Buy | 23,824,451 | .28 | 6,551,724 |
2010-06-30 | Kerins Patrick J (10% Owner) | Buy | 23,824,451 | .28 | 6,551,724 |
2010-06-30 | Champsi Farah (Other) | Buy | 11,912,224 | .28 | 3,275,861 |
2010-06-30 | Bjerkholt Eric (Sr. VP, CFO & Corp. Secretary) | Buy | 238,243 | .28 | 65,516 |
2010-04-30 | Semon Dominique | Sale | 382,542 | .98 | 373,743 |
2010-02-25 | Semon Dominique | Sale | 793,803 | .94 | 747,762 |
2009-12-14 | Hurwitz Edward (Director) | Sale | 2,232,464 | 2.01 | 4,485,020 |
2009-12-14 | Champsi Farah (10% Owner) | Sale | 2,232,464 | 2.01 | 4,485,020 |
2009-12-11 | Semon Dominique | Sale | 1,508,051 | 2.02 | 3,046,263 |
2009-07-21 | Warburg Pincus Llc (10% Owner) | Sale | 347,655 | .28 | 95,605 |
2009-07-20 | Warburg Pincus Llc (10% Owner) | Sale | 110,200 | .28 | 30,966 |
2009-07-17 | Warburg Pincus Llc (10% Owner) | Sale | 7,625 | .30 | 2,310 |
2009-07-16 | Warburg Pincus Llc (10% Owner) | Sale | 134,500 | .30 | 40,888 |
2009-07-15 | Warburg Pincus Llc (10% Owner) | Sale | 42,720 | .32 | 13,670 |
2009-07-14 | Warburg Pincus Llc (10% Owner) | Sale | 107,300 | .32 | 34,443 |
2009-07-13 | Warburg Pincus Llc (10% Owner) | Sale | 350,000 | .37 | 130,550 |
2007-05-30 | Warburg Pincus Partners Llc (10% Owner) | Buy | 677,200 | 4.43 | 2,999,996 |
2007-05-30 | Leff Jonathan S (Director) | Buy | 677,200 | 4.43 | 2,999,996 |
2007-03-21 | Swisher Daniel N Jr (President and CEO) | Buy | 5,000 | 4.26 | 21,300 |
2007-03-13 | Bjerkholt Eric (Sr. VP, Corp. Dev. & Finance) | Buy | 3,000 | 4.30 | 12,900 |
2006-12-14 | Swisher Daniel N Jr (President and CEO) | Buy | 17,900 | 4.25 | 76,128 |
2006-09-08 | Wells James A | Sale | 5,000 | 6.00 | 30,000 |
2006-03-17 | Warburg Pincus Partners Llc (10% Owner) | Buy | 805,153 | 6.21 | 5,000,000 |
2006-03-17 | Leff Jonathan S (Director) | Buy | 805,153 | 6.21 | 5,000,000 |
2005-09-27 | Biogen Idec Ma Inc (10% Owner) | Buy | 714,286 | 7.00 | 5,000,002 |
Insider trading activities including stock purchases, stock sales, and option exercises of VIRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viracta Therapeutics, Inc. (symbol VIRX, CIK number 1061027) see the Securities and Exchange Commission (SEC) website.